- Home
- YMAB vs HVII Comparison
YMAB vs HVII Comparison
Compare YMAB & HVII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- HVII
- Stock Information
- Founded
- YMAB 2015
- HVII 2024
- Country
- YMAB United States
- HVII United States
- Employees
- YMAB N/A
- HVII N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- HVII
- Sector
- YMAB Health Care
- HVII
- Exchange
- YMAB Nasdaq
- HVII NYSE
- Market Cap
- YMAB 218.4M
- HVII 260.0M
- IPO Year
- YMAB 2018
- HVII 2025
- Fundamental
- Price
- YMAB $3.89
- HVII $10.00
- Analyst Decision
- YMAB Buy
- HVII
- Analyst Count
- YMAB 11
- HVII 0
- Target Price
- YMAB $18.73
- HVII N/A
- AVG Volume (30 Days)
- YMAB 216.5K
- HVII 113.9K
- Earning Date
- YMAB 05-13-2025
- HVII 01-01-0001
- Dividend Yield
- YMAB N/A
- HVII N/A
- EPS Growth
- YMAB N/A
- HVII N/A
- EPS
- YMAB N/A
- HVII N/A
- Revenue
- YMAB $87,685,000.00
- HVII N/A
- Revenue This Year
- YMAB N/A
- HVII N/A
- Revenue Next Year
- YMAB $18.83
- HVII N/A
- P/E Ratio
- YMAB N/A
- HVII N/A
- Revenue Growth
- YMAB 3.38
- HVII N/A
- 52 Week Low
- YMAB $3.84
- HVII $9.81
- 52 Week High
- YMAB $17.47
- HVII $9.99
- Technical
- Relative Strength Index (RSI)
- YMAB 40.44
- HVII N/A
- Support Level
- YMAB $3.76
- HVII N/A
- Resistance Level
- YMAB $4.60
- HVII N/A
- Average True Range (ATR)
- YMAB 0.33
- HVII 0.00
- MACD
- YMAB -0.02
- HVII 0.00
- Stochastic Oscillator
- YMAB 15.12
- HVII 0.00
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About HVII HENNESSY CAPITAL INVESTMENT CORP VI
Hennessy Capital Investment Corp VII is a blank check company.